{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T01:15:22Z","timestamp":1790039722771,"version":"4.0.1"},"reference-count":45,"publisher":"American Medical Association (AMA)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2019.11130","type":"journal-article","created":{"date-parts":[[2019,9,11]],"date-time":"2019-09-11T11:31:49Z","timestamp":1568201509000},"page":"e1911130","source":"Crossref","is-referenced-by-count":31,"title":["A Genetic Approach to the Association Between <i>PCSK9<\/i> and Sepsis"],"prefix":"10.1001","volume":"2","author":[{"given":"QiPing","family":"Feng","sequence":"first","affiliation":[{"name":"Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Qi","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandip","family":"Chaugai","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara G.","family":"Carranza Leon","sequence":"additional","affiliation":[{"name":"Division of Diabetes, Endocrinology and Metabolism, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian","family":"Kawai","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A.","family":"Carranza Leon","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Jiang","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Zhong","sequence":"additional","affiliation":[{"name":"Division of Genetic Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee"},{"name":"Vanderbilt Genetic Institute, Vanderbilt University, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ge","family":"Liu","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Ihegword","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian M.","family":"Shaffer","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MacRae F.","family":"Linton","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Vanderbilt University, Nashville, Tennessee"},{"name":"Division of Cardiovascular Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia P.","family":"Chung","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee"},{"name":"Division of Rheumatology and Immunology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Michael","family":"Stein","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee"},{"name":"Department of Pharmacology, Vanderbilt University, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2019,9,11]]},"reference":[{"issue":"8","key":"zoi190436r1","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"issue":"13","key":"zoi190436r2","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1001\/jama.2017.13836","article-title":"Incidence and trends of sepsis in US hospitals using clinical vs claims data, 2009-2014.","volume":"318","author":"Rhee","year":"2017","journal-title":"JAMA"},{"issue":"9","key":"zoi190436r3","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1056\/NEJMra1208623","article-title":"Severe sepsis and septic shock.","volume":"369","author":"Angus","year":"2013","journal-title":"N Engl J Med"},{"issue":"258","key":"zoi190436r4","doi-asserted-by":"publisher","first-page":"258ra143","DOI":"10.1126\/scitranslmed.3008782","article-title":"PCSK9 is a critical regulator of the innate immune response and septic shock outcome.","volume":"6","author":"Walley","year":"2014","journal-title":"Sci Transl Med"},{"issue":"2","key":"zoi190436r5","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1080\/13543784.2017.1272570","article-title":"PCSK9 inhibitors in sepsis: a new potential indication?","volume":"26","author":"Momtazi","year":"2017","journal-title":"Expert Opin Investig Drugs"},{"issue":"9","key":"zoi190436r6","doi-asserted-by":"publisher","first-page":"2330","DOI":"10.1002\/jcp.25767","article-title":"PCSK9 at the crossroad of cholesterol metabolism and immune function during infections.","volume":"232","author":"Paciullo","year":"2017","journal-title":"J Cell Physiol"},{"issue":"12","key":"zoi190436r7","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1038\/nrd4492","article-title":"Sepsis: PCSK9 blockade helps clear pathogenic lipids.","volume":"13","author":"Bray","year":"2014","journal-title":"Nat Rev Drug Discov"},{"issue":"16","key":"zoi190436r8","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1016\/j.jacc.2013.07.056","article-title":"Targeting the proprotein convertase subtilisin\/kexin type 9 for the treatment of dyslipidemia and atherosclerosis.","volume":"62","author":"Urban","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"zoi190436r9","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1194\/jlr.CX00001-JLR200","article-title":"PCSK9 function and physiology.","volume":"49","author":"Peterson","year":"2008","journal-title":"J Lipid Res"},{"issue":"12","key":"zoi190436r10","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1056\/NEJMoa054013","article-title":"Sequence variations in PCSK9, low LDL, and protection against coronary heart disease.","volume":"354","author":"Cohen","year":"2006","journal-title":"N Engl J Med"},{"issue":"16","key":"zoi190436r11","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1056\/NEJMoa1501031","article-title":"Efficacy and safety of alirocumab in reducing lipids and cardiovascular events.","volume":"372","author":"Robinson","year":"2015","journal-title":"N Engl J Med"},{"issue":"16","key":"zoi190436r12","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1056\/NEJMoa1500858","article-title":"Efficacy and safety of evolocumab in reducing lipids and cardiovascular events.","volume":"372","author":"Sabatine","year":"2015","journal-title":"N Engl J Med"},{"issue":"10106","key":"zoi190436r13","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1016\/S0140-6736(17)32290-0","article-title":"Clinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: a prespecified secondary analysis of the FOURIER trial.","volume":"390","author":"Giugliano","year":"2017","journal-title":"Lancet"},{"issue":"1","key":"zoi190436r14","doi-asserted-by":"publisher","first-page":"10496","DOI":"10.1038\/s41598-018-28777-0","article-title":"Low-density lipoprotein (LDL)\u2013dependent uptake of gram-positive lipoteichoic acid and gram-negative lipopolysaccharide occurs through LDL receptor.","volume":"8","author":"Grin","year":"2018","journal-title":"Sci Rep"},{"issue":"5","key":"zoi190436r15","doi-asserted-by":"publisher","first-page":"2821","DOI":"10.1128\/IAI.69.5.2821-2828.2001","article-title":"Distribution and kinetics of lipoprotein-bound endotoxin.","volume":"69","author":"Levels","year":"2001","journal-title":"Infect Immun"},{"issue":"6","key":"zoi190436r16","doi-asserted-by":"publisher","first-page":"3280","DOI":"10.1128\/IAI.71.6.3280-3284.2003","article-title":"Distribution and kinetics of lipoprotein-bound lipoteichoic acid.","volume":"71","author":"Levels","year":"2003","journal-title":"Infect Immun"},{"issue":"15","key":"zoi190436r17","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1016\/j.jacc.2015.02.020","article-title":"Effect of naturally random allocation to lower low-density lipoprotein cholesterol on the risk of coronary heart disease mediated by polymorphisms in NPC1L1, HMGCR, or both: a 2 \u00d7 2 factorial Mendelian randomization study.","volume":"65","author":"Ference","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"6235","key":"zoi190436r18","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1126\/science.1262110","article-title":"Human genomics: the Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans.","volume":"348","author":"Ardlie","year":"2015","journal-title":"Science"},{"issue":"9","key":"zoi190436r19","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1038\/ng.3367","article-title":"A gene-based association method for mapping traits using reference transcriptome data.","volume":"47","author":"Gamazon","year":"2015","journal-title":"Nat Genet"},{"issue":"1","key":"zoi190436r20","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13073-015-0166-y","article-title":"Extracting research-quality phenotypes from electronic health records to support precision medicine.","volume":"7","author":"Wei","year":"2015","journal-title":"Genome Med"},{"issue":"1","key":"zoi190436r21","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1197\/jamia.M3378","article-title":"MedEx: a medication information extraction system for clinical narratives.","volume":"17","author":"Xu","year":"2010","journal-title":"J Am Med Inform Assoc"},{"issue":"12","key":"zoi190436r22","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1038\/nbt.2749","article-title":"Systematic comparison of phenome-wide association study of electronic medical record data and genome-wide association study data.","volume":"31","author":"Denny","year":"2013","journal-title":"Nat Biotechnol"},{"issue":"1","key":"zoi190436r23","doi-asserted-by":"publisher","first-page":"e187223","DOI":"10.1001\/jamanetworkopen.2018.7223","article-title":"Association between low-density lipoprotein cholesterol levels and risk for sepsis among patients admitted to the hospital with infection.","volume":"2","author":"Feng","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"7","key":"zoi190436r24","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1097\/00003246-200107000-00002","article-title":"Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care.","volume":"29","author":"Angus","year":"2001","journal-title":"Crit Care Med"},{"issue":"6","key":"zoi190436r25","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/S1473-3099(17)30117-2","article-title":"Application of the Third International Consensus Definitions for Sepsis (Sepsis-3) classification: a retrospective population-based cohort study.","volume":"17","author":"Donnelly","year":"2017","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"zoi190436r26","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","article-title":"Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases.","volume":"45","author":"Deyo","year":"1992","journal-title":"J Clin Epidemiol"},{"issue":"5","key":"zoi190436r27","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"issue":"11","key":"zoi190436r28","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data.","volume":"43","author":"Quan","year":"2005","journal-title":"Med Care"},{"issue":"16","key":"zoi190436r29","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1093\/bioinformatics\/btu197","article-title":"R PheWAS: data analysis and plotting tools for phenome-wide association studies in the R environment.","volume":"30","author":"Carroll","year":"2014","journal-title":"Bioinformatics"},{"issue":"22","key":"zoi190436r30","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1056\/NEJMoa1604304","article-title":"Variation in PCSK9 and HMGCR and risk of cardiovascular disease and diabetes.","volume":"375","author":"Ference","year":"2016","journal-title":"N Engl J Med"},{"issue":"10","key":"zoi190436r31","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1038\/ng.3656","article-title":"Next-generation genotype imputation service and methods.","volume":"48","author":"Das","year":"2016","journal-title":"Nat Genet"},{"issue":"10","key":"zoi190436r32","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1038\/ng.3643","article-title":"A reference panel of 64,976 haplotypes for genotype imputation.","volume":"48","author":"McCarthy","year":"2016","journal-title":"Nat Genet"},{"issue":"11","key":"zoi190436r33","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1038\/ng.2795","article-title":"Common variants associated with plasma triglycerides and risk for coronary artery disease.","volume":"45","author":"Do","year":"2013","journal-title":"Nat Genet"},{"issue":"11","key":"zoi190436r35","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1038\/ng.2797","article-title":"Discovery and refinement of loci associated with lipid levels.","volume":"45","author":"Willer","year":"2013","journal-title":"Nat Genet"},{"issue":"7307","key":"zoi190436r36","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1038\/nature09270","article-title":"Biological, clinical and population relevance of 95 loci for blood lipids.","volume":"466","author":"Teslovich","year":"2010","journal-title":"Nature"},{"issue":"3","key":"zoi190436r37","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1086\/519795","article-title":"PLINK: a tool set for whole-genome association and population-based linkage analyses.","volume":"81","author":"Purcell","year":"2007","journal-title":"Am J Hum Genet"},{"issue":"2","key":"zoi190436r38","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/0197-2456(90)90005-M","article-title":"Power and sample size calculations: a review and computer program.","volume":"11","author":"Dupont","year":"1990","journal-title":"Control Clin Trials"},{"issue":"5","key":"zoi190436r39","doi-asserted-by":"publisher","first-page":"e0155030","DOI":"10.1371\/journal.pone.0155030","article-title":"Lipopolysaccharide is cleared from the circulation by hepatocytes via the low density lipoprotein receptor.","volume":"11","author":"Topchiy","year":"2016","journal-title":"PLoS One"},{"issue":"6","key":"zoi190436r40","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1097\/SHK.0000000000000682","article-title":"Differential expression of PCSK9 modulates infection, inflammation, and coagulation in a murine model of sepsis.","volume":"46","author":"Dwivedi","year":"2016","journal-title":"Shock"},{"issue":"8","key":"zoi190436r41","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1194\/jlr.M076844","article-title":"Inhibition of PCSK9 does not improve lipopolysaccharide-induced mortality in mice.","volume":"58","author":"Berger","year":"2017","journal-title":"J Lipid Res"},{"issue":"3","key":"zoi190436r42","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1097\/CCM.0000000000003551","article-title":"Low low-density lipoprotein levels are associated with, but do not causally contribute to, increased mortality in sepsis.","volume":"47","author":"Walley","year":"2019","journal-title":"Crit Care Med"},{"issue":"2","key":"zoi190436r43","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1159\/000442976","article-title":"Increased plasma PCSK9 levels are associated with reduced endotoxin clearance and the development of acute organ failures during sepsis.","volume":"8","author":"Boyd","year":"2016","journal-title":"J Innate Immun"},{"key":"zoi190436r44","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.ebiom.2018.11.032","article-title":"Impact of PCSK9 loss-of-function genotype on 1-year mortality and recurrent infection in sepsis survivors.","volume":"38","author":"Genga","year":"2018","journal-title":"EBioMedicine"},{"issue":"4","key":"zoi190436r45","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.amjmed.2014.10.057","article-title":"Statin therapy and mortality from sepsis: a meta-analysis of randomized trials.","volume":"128","author":"Deshpande","year":"2015","journal-title":"Am J Med"},{"key":"zoi190436r34","doi-asserted-by":"crossref","unstructured":"LyallD, WardJ, BanachM, . PCSK9 genetic variants, life-long lowering of LDL-cholesterol and cognition: a large-scale Mendelian randomization study. BioRxiv. Preprint posted May 31, 2018.","DOI":"10.1101\/335877"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/article-pdf\/2\/9\/e1911130\/17860558\/feng_2019_oi_190436.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,11]],"date-time":"2019-09-11T11:31:52Z","timestamp":1568201512000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2749565"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,11]]},"references-count":45,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9,4]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2019.11130","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,11]]}}}